Pricing Log in Create free account

Heron Therapeutics, Inc. (HRTX) vs PDS Biotechnology Corporation (PDSB)

Heron Therapeutics, Inc. and PDS Biotechnology Corporation are both Biotechnology companies. Heron Therapeutics, Inc. and PDS Biotechnology Corporation are of similar size ($72.8M and $71.5M). PDS Biotechnology Corporation has the higher net margin (0.00% vs −22.5%) and the higher return on invested capital (0.00% vs −6.35%). Across the 13 metrics below, Heron Therapeutics, Inc. leads on 7 and PDS Biotechnology Corporation on 6.

Valuation

Metric HRTX PDSB Biotechnology median
P/E n/m n/m 8.50
P/S 0.45 n/m 9.71
P/B 11.70 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.11 n/m 9.21
Earnings yield (52.78%) (57.14%) (33.15%)
Free cash flow yield (17.64%) (26.53%) (25.50%)

Profitability

Metric HRTX PDSB Biotechnology median
Gross margin 70.07% 0.00% 65.16%
Operating margin (7.19%) 0.00% 0.00%
Net margin (22.52%) 0.00% 0.00%
Free cash flow margin (8.00%) 0.00% 0.00%
Return on equity 318.21% (543.97%) (56.36%)
Return on assets (14.06%) (136.65%) (48.04%)
Return on invested capital (6.35%) 0.00% 0.00%

Growth

Metric HRTX PDSB Biotechnology median
Revenue growth (TTM) 0.99% — 6.02%
EPS growth (last fiscal year) (33.33%) 28.16% 30.26%
Revenue growth, 5-year CAGR 11.81% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HRTX PDSB Biotechnology median
Debt to equity 20.65 (1.21) 0.00
Current ratio 2.49 0.57 4.72
Net debt to EBITDA (643.88) 0.50 0.96

Dividend

Metric HRTX PDSB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HRTX PDSB Biotechnology median
Market cap 71.48m 72.76m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack